Home › Primary Progressive Aphasia › NCT07260253

Remotely-supervised Neuromodulation in PPA

Investigating the Benefits of Remotely-Supervised Neuromodulation In Primary Progressive Aphasia

Who can join

Ages 40 and older · All sexes

Inclusion Criteria:

* Meets diagnostic criteria for primary progressive aphasia (PPA)
* Meets diagnostic criteria for logopenic variant PPA
* Attains score of 15 or higher on the Mini-Mental State Examination
* Has adequate hearing and vision (with hearing or vision aids, if needed)
* Is able to travel to research site and undergo MRI brain scan
* Has access to high speed internet and basic experience using a computer and the internet
* Is a fluent speaker of English
* Has a study partner who can co-enroll in the study, attend pre-treatment training at the research site, and be present for teleconference meetings, as needed

Exclusion Criteria:

* Speech and language deficits better accounted for by another neurological disorder
* Does not meet diagnostic criteria for logopenic variant PPA
* Scores less than 15 on the Mini-Mental State Examination
* Does not have a study partner who can co-enroll in the study
* Has contraindications for tDCS or MRI scan (History of seizures, head injury, craniotomy, skull surgery or fracture; History of severe or frequent migraines; Metallic implant in head or any metal in head; Pacemaker or cardioverter-defibrillator or any other stimulator; Chronic skin problems; Pregnancy)
* Has a history of stroke, epilepsy, or significant brain injury

About the study

The goal of this clinical trial is to learn whether home-based brain stimulation combined with virtual speech-language therapy can improve communication abilities in adults with logopenic variant primary progressive aphasia (lvPPA), a language disorder most often caused by Alzheimer's disease.

The main questions the study aims to answer are:

* Is combining remotely supervised transcranial direct current stimulation (tDCS) with virtual speech-language therapy feasible and acceptable for people with lvPPA? * Does this combined treatment lead to improvements in communication compared to speech-language therapy with sham (placebo) stimulation? * Do individual brain characteristics help predict who benefits most from this treatment?

Researchers will compare participants who receive active tDCS plus virtual speech-language therapy to participants who receive sham (placebo) tDCS plus virtual speech-language therapy to see if active brain stimulation enhances communication outcomes.

Participants will:

* Complete speech-language therapy sessions delivered by video visit. * Receive either active or sham tDCS that is remotely supervised and completed at home. * Complete language and cognitive testing before and after treatment. * Undergo brain imaging and other assessments to help understand treatment response.

What is being tested

• Lexical Retrieval Cascade Treatment (behavioral)
• Remotely Supervised Transcranial Direct Current Stimulation- Active (device)
• Remotely Supervised Transcranial Direct Current Stimulation - Sham (device)

Sponsor: Maya Henry · Participants: 80 · Started: Apr 15, 2026

Contact the study team

• Aphasia Lab Research Coordinator · Phone: 512-471-3420

Official record on ClinicalTrials.gov — NCT07260253

Locations in the U.S.

Conditions

• Primary Progressive Aphasia
• Aphasia
• Speech and Communication Disorders

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.